Disc Medicine, Inc.
Financials
Valuation Metrics
Disc Medicine, Inc.'s Market Cap is $3.00B. At end of 2025 it was $2.80B. Ranked #1687 of 3,118 in US market (top 54%), #599 of 1,474 on NASDAQ (top 41%), #101 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 38%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $3.00B | US#1,687/3,118 Sec#101/265 |
| Revenue | $0.00 | US#2,858/3,118 Sec#193/265 |
| Net Income | $-246M | US—/3,118 Sec—/265 |
| Total Assets | $735M | US#2,599/3,118 Sec#126/265 |
| Net Assets | $644M | US#2,059/3,118 Sec#90/265 |
| Employees | 165 | US#2,513/3,118 Sec#136/265 |
| Value | ||
| P/B | 4.66x | US#2,192/3,118 Sec#139/265 |
| FCF Yield | -6.58% | US—/3,118 Sec—/265 |
| Profitability | ||
| ROE | -38.17% | US#2,608/3,118 Sec#131/265 |
| ROA | -33.45% | US#2,900/3,118 Sec#167/265 |
| Financial Health | ||
| Debt Ratio | 14.11% | US#160/3,118 Sec#65/265 |
| Total Debt | $61M | US#2,553/3,118 Sec#146/265 |
| FCF | $-198M | US#2,775/3,118 Sec#208/265 |
| Cash | $99M | US#2,236/3,118 Sec#175/265 |
| Current Ratio | 24.14x | US#98/3,118 Sec#16/265 |
| Performance | ||
| 1Y Return | -8.77% | US#2,002/3,118 Sec#158/265 |
| 1M Return | 21.93% | US#160/3,118 Sec#12/265 |
| From 52W High | -20.94% | US#1,412/3,118 Sec#79/265 |
| 1Y MDD | -40.77% | US#1,961/3,118 Sec#125/265 |
| Trading | ||
| Volume | 354,089 shares | US#1,945/3,118 Sec#190/265 |
| Trading Value | $28M | US#1,353/3,118 Sec#86/265 |
| Per Share | ||
| EPS | $-6.44 | US—/3,118 Sec—/265 |
| BPS | $16.86 | US#1,415/3,118 Sec#44/265 |
Company Info
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.